The Liv Hospital Medical Writer Team creates evidence-based health content.
View author profile →Overview
What Is Invasive Ductal Carcinoma?
Invasive ductal carcinoma is a type of breast cancer that starts in the lining of a milk duct. The word “invasive” means that abnormal cells have grown through the duct wall into nearby breast tissue. It is the most common type of invasive breast cancer and is one of the main carcinomas of the breast. Invasive ductal carcinoma can affect people of different ages and sexes, including men and women.
Symptoms
Symptoms of Invasive Ductal Carcinoma
Invasive ductal carcinoma may cause no noticeable symptoms and may be found during screening. When changes do occur, they can resemble other breast conditions, so they should not be self-diagnosed. A new or persistent breast change should be assessed by a healthcare professional.
- A new breast lump or thickened area may develop.
- Breast swelling may occur in part or all of the breast.
- The skin may develop dimpling or puckering (peau d’orange).
- The nipple may turn inward (nipple inversion).
- Fluid may come from the nipple (nipple discharge).
- Breast pain or tenderness may occur.
- A lymph node may become enlarged in the underarm (axillary lymphadenopathy).
Causes
What Causes Invasive Ductal Carcinoma?
Invasive ductal carcinoma develops when genetic changes cause cells lining a breast duct to grow and divide abnormally. Over time, the abnormal cells can break through the duct wall and invade nearby breast tissue, which is what makes this an invasive carcinoma. Several inherited, hormonal, environmental, and chance-related factors may contribute, and a single cause usually cannot be identified for an individual case.
How Is Ductal Carcinoma in Situ Different?
Carcinoma in situ means that abnormal cancer cells remain in the place where they began. Ductal carcinoma in situ, or DCIS, remains inside a milk duct, while invasive ductal carcinoma has entered the surrounding breast tissue. DCIS can sometimes progress if untreated, but no single behavior or exposure causes every case of invasive carcinoma.
Risk Factors
Risk Factors for Invasive Ductal Carcinoma
Non-modifiable risk factors
- Risk increases with age, although invasive breast cancer can occur in younger adults.
- A personal history of breast cancer or certain noncancerous breast conditions may increase risk.
- A family history of breast or ovarian cancer may indicate increased inherited risk.
- Inherited gene variants, including changes in BRCA1, BRCA2, or other genes, can raise risk.
- Dense breasts can make abnormalities harder to see on mammography and are associated with increased risk.
- Prior radiation treatment to the chest, especially at a younger age, can increase risk.
Potentially modifiable or manageable factors
- Drinking alcohol can increase breast cancer risk, with greater exposure generally linked to greater risk.
- Regular physical activity may help lower risk compared with an inactive lifestyle.
- Maintaining a healthy weight after menopause may reduce risk associated with excess body weight.
- Some hormone therapies used around menopause may affect risk and should be discussed with a clinician.
- Reducing a modifiable risk factor can help lower risk but cannot eliminate the possibility of invasive ductal carcinoma.
Side Effects & Complications
Side Effects and Complications
Possible complications of the disease
- Invasive ductal carcinoma may spread to nearby lymph nodes.
- Advanced disease may spread to distant organs such as the bones, liver, lungs, or brain.
- Cancer can return in the breast, chest area, or another part of the body after treatment.
- Advanced disease may cause pain, weakness, breathing problems, or other effects depending on where it has spread.
Common treatment side effects
- Surgery may cause pain, numbness, limited shoulder movement, infection, or lymphedema after lymph-node treatment.
- Radiation therapy may cause skin redness or irritation and fatigue in the treated area.
- Chemotherapy may cause fatigue, nausea, hair loss, mouth changes, infection risk, or changes in blood counts.
- Endocrine therapy may cause hot flashes, joint symptoms, sexual changes, or bone-density loss.
- Targeted therapy or immunotherapy may cause infusion reactions or other organ-specific immune or treatment effects.
Treatment warning
When to contact the care team
Contact your care team promptly for a fever, breathing difficulty, sudden swelling, uncontrolled bleeding, severe pain, confusion, or any rapidly worsening symptom during treatment. If symptoms are severe or life-threatening, call emergency services.
Diagnosis & Staging
Diagnosis and Staging
Evaluation usually begins with a clinical breast examination and diagnostic mammography or ultrasound. Breast MRI may be recommended when additional imaging is needed. A needle biopsy guided by imaging removes tissue for pathology, which confirms whether invasive ductal carcinoma is present. The pathology report may include the tumor type, grade, margins, lymphovascular invasion, and hormone-receptor and HER2 results; these findings help guide staging and treatment.
What a pathology report may show
The report may call the tumor invasive ductal carcinoma of no special type, sometimes shortened to ductal NOS. It may describe whether the cancer is grade 1, grade 2, or grade 3, based on how different the cells look and how actively they appear to grow. It can also report whether the surgical margins are clear, whether lymphovascular invasion is present, and whether the tumor has estrogen or progesterone receptors or excess HER2. These details are different from the cancer stage, which also considers tumor size, lymph nodes, and distant spread.
| Stage | General meaning |
|---|---|
| Stage 0 | Noninvasive disease such as ductal carcinoma in situ that remains within a duct. |
| Stage I | A small invasive cancer with limited or no lymph-node involvement. |
| Stage II | A larger tumor and/or limited involvement of regional lymph nodes. |
| Stage III | Locally advanced disease involving nearby tissues or multiple regional lymph nodes. |
| Stage IV | Cancer that has spread to distant organs, also called metastatic disease. |
Treatment Options
Treatment Options
Treatment for invasive ductal carcinoma (IDC) depends on the stage of the cancer, tumor size, lymph node involvement, hormone receptor status, and HER2 status. Surgery is usually an important part of treatment and may include breast-conserving surgery (lumpectomy) or mastectomy. Lymph nodes may also be examined or removed to determine whether the cancer has spread.
Radiation therapy is often used after breast-conserving surgery and may also be recommended after mastectomy in certain cases. Hormone therapy, such as tamoxifen or aromatase inhibitors, may be used for hormone receptor-positive tumors. Chemotherapy can be given before or after surgery, depending on the risk of recurrence and other tumor characteristics. For HER2-positive cancers, targeted therapies such as trastuzumab may be used. Immunotherapy may also be considered for some patients, particularly in certain types of advanced or triple-negative breast cancer. Treatment is individualized according to the patient’s cancer characteristics and overall health.
Prevention & Screening
Prevention and Screening
Invasive ductal carcinoma cannot always be prevented, but some steps may lower risk. These include limiting alcohol, staying physically active, maintaining a healthy weight, discussing the risks and benefits of hormone therapy, and seeking genetic counseling when family or personal history suggests inherited risk. Screening mammography can find breast cancer before symptoms appear. People with higher inherited or personal risk may also be offered supplemental MRI, ultrasound, or an earlier screening schedule.
How screening recommendations vary
Screening guidance
Choose a screening plan based on risk
Follow current, personalized screening guidance from a clinician because recommendations vary by age, breast density, family history, genetic risk, and prior treatment. Ask which test and schedule are appropriate for you.
Outlook and Prognosis
Outlook and Prognosis
Many cases of invasive ductal carcinoma, especially those found before they spread to distant organs, can be treated successfully. Outlook varies widely, so a diagnosis does not determine one person’s outcome by itself. Your oncology team can explain how the disease’s features and response to treatment affect your individual situation.
Factors that affect prognosis
Important factors include stage, tumor grade, lymph-node involvement, hormone-receptor and HER2 status, and response to treatment. Genomic testing may provide additional information for selected people when treatment decisions are uncertain. Overall health and whether the cancer has spread also influence prognosis; invasive ductal carcinoma grade 1, grade 2, and grade 3 tumors can have different growth patterns and treatment considerations.
Survivorship & Follow-up
Survivorship and Follow-up
After treatment, follow-up visits help monitor for recurrence and manage ongoing health needs. Your plan may include breast imaging or other tests based on your treatment history, medication adherence, symptoms, and personal risk. Take medicines as prescribed and tell the care team about new or persistent symptoms rather than waiting for the next appointment.
- Recurrence monitoring may include scheduled visits, breast imaging, and other tests when symptoms or treatment history indicate they are needed.
- Lymphedema prevention and treatment should be discussed if lymph nodes were removed or treated.
- Bone health may need attention after menopause or during some endocrine treatments.
- Fertility, sexual health, and menopause concerns can be addressed before, during, or after treatment.
- Cardiac health may need monitoring after treatments that can affect the heart.
- Pain, fatigue, sleep problems, and physical activity can be included in the recovery plan.
- Counseling, support groups, and other emotional support can help with anxiety, grief, and adjustment after cancer treatment.
